Walleye Trading’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.58M Sell
7,500
-17,600
-70% -$3.79M ﹤0.01% 1847
2025
Q4
$5.16M Sell
25,100
-12,000
-32% -$2.26M 0.01% 1284
2025
Q3
$5.82M Sell
37,100
-4,100
-10% -$633K 0.01% 1184
2025
Q2
$6.92M Buy
41,200
+9,700
+31% +$1.44M 0.01% 1011
2025
Q1
$4.34M Sell
31,500
-2,000
-6% -$255K 0.01% 1188
2024
Q4
$3.96M Hold
33,500
0.01% 1302
2024
Q3
$3.7M Buy
33,500
+12,000
+56% +$1.25M 0.01% 1302
2024
Q2
$2.11M Sell
21,500
-13,000
-38% -$1.32M 0.01% 1572
2024
Q1
$3.86M Sell
34,500
-48,200
-58% -$5.2M 0.01% 1308
2023
Q4
$8.34M Buy
82,700
+1,400
+2% +$139K 0.02% 890
2023
Q3
$7.06M Buy
81,300
+8,600
+12% +$777K 0.02% 879
2023
Q2
$6.88M Sell
72,700
-55,600
-43% -$4.7M 0.02% 757
2023
Q1
$9.69M Sell
128,300
-137,000
-52% -$10.3M 0.02% 643
2022
Q4
$20.4M Sell
265,300
-68,200
-20% -$5.18M 0.06% 349
2022
Q3
$22.2M Buy
333,500
+105,500
+46% +$6.69M 0.07% 286
2022
Q2
$11.9M Sell
228,000
-60,300
-21% -$3.43M 0.04% 526
2022
Q1
$16.3M Buy
288,300
+33,300
+13% +$1.78M 0.05% 424
2021
Q4
$13.1M Buy
255,000
+151,700
+147% +$7.44M 0.04% 466
2021
Q3
$5.11M Buy
103,300
+50,400
+95% +$2.73M 0.02% 909
2021
Q2
$3.02M Sell
52,900
-4,200
-7% -$245K 0.01% 1163
2021
Q1
$3.47M Sell
57,100
-2,700
-5% -$149K 0.02% 904
2020
Q4
$3.2M Buy
59,800
+35,700
+148% +$1.85M 0.01% 1027
2020
Q3
$1.13M Sell
24,100
-2,600
-10% -$133K 0.01% 1560
2020
Q2
$1.39M Sell
26,700
-19,000
-42% -$979K 0.01% 1404
2020
Q1
$2.19M Sell
45,700
-25,900
-36% -$1.34M 0.02% 776
2019
Q4
$3.62M Buy
71,600
+67,700
+1,736% +$3.5M 0.03% 783
2019
Q3
$184K Sell
3,900
-18,700
-83% -$854K ﹤0.01% 2982
2019
Q2
$1.06M Sell
22,600
-9,100
-29% -$420K 0.01% 1543
2019
Q1
$1.53M Sell
31,700
-19,400
-38% -$972K 0.01% 1294
2018
Q4
$2.28M Buy
51,100
+13,900
+37% +$725K 0.02% 975
2018
Q3
$2.01M Sell
37,200
-74,500
-67% -$3.81M 0.01% 1332
2018
Q2
$5.45M Buy
111,700
+69,700
+166% +$3.95M 0.03% 555
2018
Q1
$2.63M Buy
42,000
+32,400
+338% +$2.22M 0.02% 960
2017
Q4
$588 Sell
9,600
-600
-6% -$37.1K ﹤0.01% 2455
2017
Q3
$682 Sell
10,200
-8,800
-46% -$622K ﹤0.01% 2197
2017
Q2
$1.48K Buy
19,000
+6,600
+53% +$498K 0.01% 1429
2017
Q1
$1.01K Buy
12,400
+7,300
+143% +$575K 0.01% 1634
2016
Q4
$366K Sell
5,100
-18,300
-78% -$1.32M ﹤0.01% 2339
2016
Q3
$1.82M Sell
23,400
-42,500
-64% -$3.43M 0.01% 1037
2016
Q2
$5.14M Buy
65,900
+57,400
+675% +$4.58M 0.03% 438
2016
Q1
$698K Buy
8,500
+2,000
+31% +$163K 0.01% 1692
2015
Q4
$581K Sell
6,500
-42,300
-87% -$3.59M 0.01% 1731
2015
Q3
$3.75M Buy
48,800
+46,400
+1,933% +$3.88M 0.03% 396
2015
Q2
$201K Sell
2,400
-3,000
-56% -$265K ﹤0.01% 2471
2015
Q1
$487K Sell
5,400
-600
-10% -$51.7K ﹤0.01% 1510
2014
Q4
$484K Buy
6,000
+3,000
+100% +$237K ﹤0.01% 1599
2014
Q3
$225K Sell
3,000
-1,500
-33% -$109K ﹤0.01% 1987
2014
Q2
$308 Buy
+4,500
New +$306K ﹤0.01% 1653
2014
Q1
Sell
-700
Closed -$47K 3531
2013
Q4
$47K Sell
700
-43,900
-98% -$2.68M ﹤0.01% 2854
2013
Q3
$2.33M Buy
44,600
+44,400
+22,200% +$2.26M 0.02% 489
2013
Q2
$10K Buy
+200
New +$9.13K ﹤0.01% 2663

Other funds holding CAH

Walleye Trading's CAH Position: Q1 2026 in Review

Walleye Trading reduced its Cardinal Health (CAH) stake by 13% in Q1 2026, selling an estimated $219K and leaving 6,917 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #1897.

Walleye Trading first reported a position in CAH in Q3 2013 and has held it in 31 quarters since. The position peaked at $5.9M in Q2 2018. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Walleye Trading held 6,917 shares of Cardinal Health worth $1.46M as of Q1 2026.
  • Walleye Trading sold 1,015 Cardinal Health shares in Q1 2026, an estimated $219K.
  • Cardinal Health made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #1897 holding.
  • Walleye Trading first reported a position in Cardinal Health in Q3 2013 and has held it in 31 quarters since.
  • Walleye Trading's Cardinal Health position peaked at $5.9M in Q2 2018.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.